Colon & Rectum Evaluations
To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.
Sign in | Free Trial | Subscribe | Recommend to Library
New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.
SECTION HEADS
Section Topics
- » Anal incontinence
- » Anatomy of the colon, rectum & anus
- » Appendiceal pathology
- » Colitis (ulcerative, ischemic, Crohn's, infectious, etc.)
- » Developmental abnormalities of the colon & anorectum
- » Diverticular disease
- » Functional disorders (chronic constipation, irritable bowel syndrome, functional diarrhea, etc.)
- » Neoplasms of the anus & anal margin
- » Neoplasms of the large bowel (polyps, polyposis syndromes, malignant neoplasms)
- » Non-neoplastic disorders of the ano-rectum (e.g. hemorrhoids, fissures, abscess, STDs)
LATEST EVALUATION
Joseph Pisegna, University of California, Los Angeles, USA. F1000 Pharmacology & Drug Discovery
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
5 Evaluations, most recent by
Joseph Pisegna, University of California, Los Angeles, USA. F1000 Pharmacology & Drug Discovery
- New Finding
- Good for Teaching
- Confirmation
- Controversial
INDIVIDUALS
Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.
Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.
RECOMMENDATIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
LIBRARIANS & INFORMATION MANAGERS
Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.
FREE ACCESS
Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
